Kaplan-Meier survival analysis showed that low GNG2 expression was associated with worse OS and DFS in patients with BC (Fig. 2E and F), while the expression of EGF, RhoA, Cdc42, and CDK1 had no significant effect on OS and DFS (data not shown). The gene discussed is EGF; the disease is breast cancer.